|
|
Deltic House, Kingfisher Way, Silverlink Business Park Wallsend, Tyne and Wear NE28 9NX United Kingdom phone:44-191-296-9369 fax:44-191-296-9368
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.cambridgelaboratories.com
|
|
| Research Sector |
Healthcare Services |
|
 |
| Summary Description |
| Specialy pharmaceuticals for oncology, urology and neurology |
 |
| Management |
| Dr John Padfield, Chairman; Bernard Taylor CBE, Director; Handel Evans, Director; Henry Wendt CBE, Director; Mark Evans, Chief Executive Officer; David Wildy - Chief Financial Officer |
| |
|
|
| |
|
| Keywords |
| cancer, urological, neurology, oncology, pharmaceuticals, central, nervous, system, cns |
|
|
|
| Description |
|
Cambridge Laboratories Limited is a provider of specialized pharmaceuticals for secondary care physicians with a particular focus on oncology, urology and neurology. |
 |
| Products / Services |
Cambridge Laboratories's primary areas of specialty are neurology and oncology with its principal product being for the treatment of hyperkinetic movement disorders and tardive dyskinesia. Cambridge' current product portfolio consists of 23 products in the following areas: Central Nervous System (CNS), Oncology and Specialist Niche Hospital Products. The company' s portfolio include: Aloxi, Gelclair, ImmuCyst, Xenazine, Nabilone, Nitoman' (tetrabenazine) and Volplex and Xenazine.
|
 |
 |
|
|
|
|
|
|